Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

The recent reduction of live attenuated influenza vaccine (LAIV) effectiveness in multivalent formulations was particularly associated with the A(H1N1)pdm09 component. In the 2017 the WHO vaccine composition committee changed its recommendations for the A(H1N1)pdm09 component to include an A/Michiga...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine X
Main Authors: Shcherbik, Svetlana, Pearce, Nicholas, Carney, Paul, Bazhenova, Ekaterina, Larionova, Natalie, Kiseleva, Irina, Rudenko, Larisa, Kumar, Amrita, Goldsmith, Cynthia S., Dugan, Vivien, Stevens, James, Wentworth, David E., Bousse, Tatiana
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Regular paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668239/
https://ncbi.nlm.nih.gov/pubmed/31384746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados